临床药师参与救治1例鲍曼不动杆菌所致颅内感染的用药分析  

Analysis of Drug Use of Clinical Pharmacist Participating in the Treatment of Intracranial Infection Caused by Acinetobacter baumannii

作　　者：李明[1] 隋建美[1] 杨继红[1] 郑志昌[1] 

机构地区：[1]贵阳医学院附属医院药剂科,贵阳550004

出　　处：《中国药房》2012年第42期4025-4027,共3页China Pharmacy

摘　　要：目的:临床药师通过参与鲍曼不动杆菌导致颅内感染患者的救治过程,探索最佳的药物治疗方案。方法:临床药师参加临床治疗团队,参与患者治疗全过程,为危重患者的抢救制订药物治疗方案提供合理化建议。结果:临床药师通过认真分析患者的病情,提出了合理化建议,被临床医师采纳,取得了很好的疗效。结论:临床药学服务对患者的治疗是有帮助的,对于鲍曼不动杆菌所致的颅内感染,头孢哌酮/舒巴坦钠可作为首选药物。OBJECTIVE： To explore optimal drug therapy scheme through clinical pharmacists participating in treatment pro- cess of intracranial infarction caused by Acinetobacter baumannii. METHODS ： Clinical pharmacists joined clinical treatment team and participated in whole treatment process to establish drug therapy scheme for critical patients rescue and provide rational sugges- tion. RESULTS： Clinical pharmacists seriously analyzed patient＇s condition and put forward rational suggestions, which were adopt- ed by the clinicians, all the things obtained good effect. CONCLUSION： Clinical pharmaceutical care is helpful to patient＇s treat- ment. As for A. baumannii-caused intracranial infection, Cefoperazone/sulbactam sodium is the first chioce.

关 键 词：临床药师 鲍曼不动杆菌 颅内感染 美罗培南 头孢哌酮/舒巴坦钠 

分 类 号：R978.1[医药卫生—药品] R969.3[医药卫生—药学]